797 related articles for article (PubMed ID: 28107736)
1. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
2. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
[TBL] [Abstract][Full Text] [Related]
3. Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration.
Tzvetkov NT; Antonov L
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):960-967. PubMed ID: 28726524
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
5. Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.
Tzvetkov NT; Stammler HG; Georgieva MG; Russo D; Faraone I; Balacheva AA; Hristova S; Atanasov AG; Milella L; Antonov L; Gastreich M
Eur J Med Chem; 2019 Oct; 179():404-422. PubMed ID: 31265934
[TBL] [Abstract][Full Text] [Related]
6. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
[TBL] [Abstract][Full Text] [Related]
7. (Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons.
Tzvetkov NT; Stammler HG; Hristova S; Atanasov AG; Antonov L
Eur J Med Chem; 2019 Jan; 162():793-809. PubMed ID: 30522087
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
10. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
Zarmouh NO; Eyunni SK; Soliman KF
BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase inhibitory activity of methoxy-substituted chalcones.
Mathew B; Mathew GE; Ucar G; Joy M; Nafna EK; Lohidakshan KK; Suresh J
Int J Biol Macromol; 2017 Nov; 104(Pt A):1321-1329. PubMed ID: 28577983
[TBL] [Abstract][Full Text] [Related]
12. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
[TBL] [Abstract][Full Text] [Related]
13. Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
Rullo M; La Spada G; Miniero DV; Gottinger A; Catto M; Delre P; Mastromarino M; Latronico T; Marchese S; Mangiatordi GF; Binda C; Linusson A; Liuzzi GM; Pisani L
Eur J Med Chem; 2023 Jul; 255():115352. PubMed ID: 37178666
[TBL] [Abstract][Full Text] [Related]
14. Monoamine Oxidase Inhibitory Activity: Methyl- versus Chlorochalcone Derivatives.
Mathew B; Uçar G; Mathew GE; Mathew S; Kalatharakkal Purapurath P; Moolayil F; Mohan S; Varghese Gupta S
ChemMedChem; 2016 Dec; 11(24):2649-2655. PubMed ID: 27902880
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.
Farina R; Pisani L; Catto M; Nicolotti O; Gadaleta D; Denora N; Soto-Otero R; Mendez-Alvarez E; Passos CS; Muncipinto G; Altomare CD; Nurisso A; Carrupt PA; Carotti A
J Med Chem; 2015 Jul; 58(14):5561-78. PubMed ID: 26107513
[TBL] [Abstract][Full Text] [Related]
19. New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
Pan ZX; He X; Chen YY; Tang WJ; Shi JB; Tang YL; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Jun; 80():278-84. PubMed ID: 24793878
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological investigation and molecular docking study of N-malonyl-1,2-dihydroisoquinoline derivatives as brain specific and shelf-stable MAO inhibitors.
Abd El-Gaber MK; Hassan HY; Mahfouz NM; Farag HH; Bekhit AA
Eur J Med Chem; 2015 Mar; 93():481-91. PubMed ID: 25732770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]